The Language of the Mind

3. Life-threatening condition caused by excess serotonergic activity, characterized by autonomic instability, hyperreflexia, and altered mental status.
6. Late-onset involuntary choreoathetoid movements caused by long-term dopamine D2 receptor blockade
14. Neonatal bilirubin encephalopathy risk linked to ceftriaxone.
17. Term describing the adverse effect of muscarinic blockade causing dry mouth, blurred vision, and confusion.
18. Extrapyramidal side effect presenting with resting tremor, rigidity, and slowed movements due to dopamine blockade.
19. Neurotransmitter most implicated in reward, psychosis, and movement disorders.
20. Neurological movement disorder causing involuntary sustained muscle contractions and facial grimacing.

1. Inability to remain still, often caused by medications characterized by fidgeting, pacing, rocking, or foot tapping, leading to significant anxiety and restlessness.
2. Negative symptom of schizophrenia involving reduced emotional expression.
4. Seven-item scale used to screen and assess severity of generalized anxiety disorder.
5. Endocrine side effect most associated with risperidone and paliperidone.
7. Rare but life-threatening dermatologic reaction often linked to antiepileptics, sulfa drugs, or lamotrigine; involves mucosal blistering.
8. Describes a patient with diminished motivation and indifference to surroundings.
9. Add on behaviors or experiences such as hallucinations and delusion not present in a normal healthy person.
10. A reduction or absence of normal behaviors, emotions and drives.
11. Core symptom of major depressive disorder defined as loss of interest or inability to experience pleasure.
12. A hallmark of Bipolar II
13. Bipolar mood episode marked by elevated or irritable mood, decreased need for sleep, grandiosity, and impaired functioning for at least 1 week.
15. Persistent pattern of excessive worry lasting at least 6 months.
16. Nine-item screening tool used to assess severity of depression.